Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma

Kartik Vasan1,2, Sunaina Anand3, Laveniya Satgunaseelan3

  • 1Central Clinical School, University of Sydney, Sydney, Australia.

Journal of Surgical Oncology
|September 14, 2020
PubMed
Abstract

Insights

The study found a 9.1% incidence of DNA mismatch repair (MMR) deficiency in advanced head and neck squamous cell carcinomas. This deficiency appears sporadic, with no link to patient age or other clinical factors.

Area of Science:

  • Oncology
  • Genetics
  • Immunology

Background:

  • Advanced cutaneous head and neck squamous cell carcinomas (HNcSCC) present significant treatment challenges.
  • Immune checkpoint inhibitors are approved for DNA mismatch repair (MMR) deficient cancers.
  • Understanding MMR deficiency in HNcSCC is crucial for treatment strategies.

Purpose of the Study:

  • To determine the incidence of MMR deficiency in advanced HNcSCC.
  • To investigate the association between MMR deficiency and clinicopathological factors.
  • To assess the potential link between MMR deficiency and patient outcomes.

Main Methods:

  • Immunohistochemistry was used to detect MMR protein expression (hMLH1, hMSH2, hMSH6, hPMS2).
  • A cohort of 176 HNcSCC patients treated with curative intent was analyzed.
  • Clinicopathological and survival data were collected prospectively.

Main Results:

  • The incidence of MMR protein deficiency was 9.1% in the studied HNcSCC cohort.
  • No significant association was found between MMR deficiency and patient age.
  • MMR deficiency did not correlate with metachronous malignancies or survival outcomes.

Conclusions:

  • Advanced HNcSCC exhibits a notable incidence of MMR deficiency.
  • The sporadic nature of MMR deficiency in HNcSCC is suggested by the lack of association with early onset or metachronous malignancies.
  • Further research may clarify the role of MMR deficiency in HNcSCC treatment response.

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.0K
Mismatch Repair01:36

Mismatch Repair

Overview
43.1K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.7K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
40.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.6K